5.07 USD
↗ 0.17 (3.47%)AT CLOSE (03:59 PM EDT)
PolyPid Ltd. Ordinary Shares
PYPDNASDAQ • USD
4.98
↘ 0.09 (1.76%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
4.98
↘ 0.09 (1.76%)
Market: CLOSED
Shares of PolyPid Ltd. Ordinary Shares (PYPD) are trading at $5.07. The technical outlook is "Neutral" based on moving average alignment, RSI, and MACD signals. Notable factors include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 9, 2026.
Open?$4.91
High?$5.16
Low?$4.90
Prev. Close?$4.90
Volume?60.2K
Avg. Volume?N/A
VWAP?$5.00
Bid / Ask
Bid?$4.77 × 200
Ask?$5.20 × 900
Spread?$0.43
Midpoint?$4.98
Valuation & Ratios
Market Cap?103.0M
Shares Out?19.1M
Float?12.5M
Float %?61.7%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.01%Low
Short Interest?126.2K
Days to Cover?1.8
Free Float12.5M
Avg Daily Volume70.0K
Settlement Date2026-09-30